October 27, 2016

OICR’s Transformative Pathology Program contributes to recent PanCuRx findings

Ilinca Lungu, a Research Technician in OICR’s Transformative Pathology Program, talks about her group’s contributions to recent findings from the PanCuRx Translational Research Initiative.

Access to the Transformative Pathology Program’s resources and expertise is available to the research community through Diagnostic Development in OICR’s Collaborative Research Resources Directory. For more information about how you can access these services, visit oicr.on.ca/collaborative-research-resources.

September 21, 2016

New partnership brings Toronto researchers together to better understand the molecular origins of breast cancer

Slide preperation

Researchers from the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital have enlisted the help of OICR’s Transformative Pathology Program in their ongoing research to identify common biomarkers for breast cancer – and ultimately to better diagnose and target treatment for patients.

Continue reading – New partnership brings Toronto researchers together to better understand the molecular origins of breast cancer

August 17, 2016

Dr. John Bartlett discusses why new retrospective breast cancer study could lead to better diagnosis and treatment for patients

Fu Yan - In the lab.

OICR has announced a new retrospective study that will help to identify mutations for breast cancer, increasing understanding of the disease and potentially leading to better diagnosis in the future. The study is led by Dr. John Bartlett, Director of OICR’s Transformative Pathology Program and Dr. Harriet Feilotter, Department of Pathology and Molecular Medicine, Queen’s University. We spoke to Dr. Bartlett about why this study is important for the future of breast cancer diagnosis and treatment. 

Continue reading – Dr. John Bartlett discusses why new retrospective breast cancer study could lead to better diagnosis and treatment for patients